New: EnSight Multimode Plate Readers Perkin Elmer

25 April 2019 ─  /  Analytical Sciences  by

The EnSight™ Multimode Plate Reader is the first benchtop system to offer well-imaging alongside label-free and labeled detection technologies. Drawing on over 20 years of experience in multimode detection and 10 years in cellular imaging, the EnSight system’s unique combination of industry-leading detection technologies enables you to take a truly orthogonal approach to your research and gain new insights from your assays that you could not achieve before.

 More Confidence in Your Results with Orthogonal Assays

With a unique combination of technologies to choose from, not only can you perform a wide range of assays on a single system but you can also confirm your findings using different technologies for greater confidence that your results are biologically relevant, not biased to a technology.  

– Choose from a range of technologies: Well-Imaging, Corning® Epic® Label-free Technology, Alpha Technology, LANCE®TR-FRET and DELFIA® TRF, Absorbance (filter- and monochromator-based), Fluorescence (top- and bottom-reading) and Ultra-Sensitive Luminescence

– Optical label-free technology provides richer and more physiologically relevant information about cellular signaling mechanisms and multiple signaling pathways, and is also designed for biochemical binding assays  

– Alpha Technology from the industry leader provides the best performance AlphaLISA® and AlphaScreen® detection, with results in half the time of ELISA 

– Time-resolved fluorescence delivers high sensitivity for biological and cellular assays 

– Upgrade options to keep up with your lab’s changing needs

Read also...

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

23 September 2025

Analytical Sciences

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

HTDS is pleased to announce the signing of a strategic partnership with Oxford Nanopore Technologies, a UK-based company that is a pioneer and globally recognized for its DNA and RNA sequencing solutions. This new agreement allows HTDS to strengthen its portfolio of analytical solutions and offer its customers a breakthrough technology that is transforming genomic and biological research. Oxford Nanopore : a unique technology to analyze lifeWith the mission to enable “the analysis of anything, by anyone, anywhere”, Oxford Nanopore has developed an innovative sequencing technology based on nanopores.This approach provides researchers and industry professionals with real-time, accurate, flexible, and scalable nucleic acid analysis, opening new perspectives in: Plant and animal genomicsAgriculture and food sciencesEnvironmental research and conservationAlready adopted in more than 125 countries, this technology is revolutionizing our understanding of life and accelerating scientific progress. A complete range of solutions tailored to every projectThrough this partnership, HTDS now distributes the entire Oxford Nanopore portfolio, covering all needs, from individual research to large-scale projects:MinION™ : a portable, personal sequencer, ideal for generating rapid data directly in the field or in the lab.GridION™ : a flexible benchtop sequencer, integrating data processing for multiple simultaneous analyses.PromethION™ (P2 Solo, P2 Integrated, PromethION 24) : a high-throughput platform for projects requiring massive volumes of genomic data.ElysION™ : a fully automated solution, from sample preparation to data analysis.In addition to these platforms, Oxford Nanopore provides a complete sequencing ecosystem, including flow cells and sample preparation kits, as well as control and analysis software such as MinKNOW™ and EPI2ME™, making sequencing accessible even to researchers without bioinformatics expertise. HTDS : a trusted partner for your genomics projectsBy partnering with Oxford Nanopore, HTDS reaffirms its commitment to offering its customers the most innovative technologies to meet their scientific and industrial needs.Research laboratories, academic centers, and industry players will now benefit from powerful, scalable, and tailored tools to address today’s challenges in genomics, health, and the environment.